COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.

The global COVID-19 Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Testing.

Report Scope

The COVID-19 Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the COVID-19 Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of COVID-19 Diagnostic Testing Market Report

Report Metric	Details
Report Name	COVID-19 Diagnostic Testing Market
CAGR	5%
Segment by Type	Nucleic Acid Testing Antibody Testing
Segment by Application	Hospitals Scientific Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the COVID-19 Diagnostic Testing Market report?

Ans: The main players in the COVID-19 Diagnostic Testing Market are Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE

What are the Application segmentation covered in the COVID-19 Diagnostic Testing Market report?

Ans: The Applications covered in the COVID-19 Diagnostic Testing Market report are Hospitals, Scientific Research

What are the Type segmentation covered in the COVID-19 Diagnostic Testing Market report?

Ans: The Types covered in the COVID-19 Diagnostic Testing Market report are Nucleic Acid Testing, Antibody Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Nucleic Acid Testing

1.2.3 Antibody Testing

1.3 Market by Application

1.3.1 Global COVID-19 Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Scientific Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global COVID-19 Diagnostic Testing Market Perspective (2019-2030)

2.2 COVID-19 Diagnostic Testing Growth Trends by Region

2.2.1 Global COVID-19 Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 COVID-19 Diagnostic Testing Historic Market Size by Region (2019-2024)

2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Region (2025-2030)

2.3 COVID-19 Diagnostic Testing Market Dynamics

2.3.1 COVID-19 Diagnostic Testing Industry Trends

2.3.2 COVID-19 Diagnostic Testing Market Drivers

2.3.3 COVID-19 Diagnostic Testing Market Challenges

2.3.4 COVID-19 Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top COVID-19 Diagnostic Testing Players by Revenue

3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2019-2024)

3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2019-2024)

3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue

3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio

3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2023

3.5 COVID-19 Diagnostic Testing Key Players Head office and Area Served

3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service

3.7 Date of Enter into COVID-19 Diagnostic Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 COVID-19 Diagnostic Testing Breakdown Data by Type

4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2019-2024)

4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2025-2030)

5 COVID-19 Diagnostic Testing Breakdown Data by Application

5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2019-2024)

5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America COVID-19 Diagnostic Testing Market Size (2019-2030)

6.2 North America COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)

6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe COVID-19 Diagnostic Testing Market Size (2019-2030)

7.2 Europe COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe COVID-19 Diagnostic Testing Market Size by Country (2019-2024)

7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size (2019-2030)

8.2 Asia-Pacific COVID-19 Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America COVID-19 Diagnostic Testing Market Size (2019-2030)

9.2 Latin America COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)

9.4 Latin America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size (2019-2030)

10.2 Middle East & Africa COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cellex

11.1.1 Cellex Company Detail

11.1.2 Cellex Business Overview

11.1.3 Cellex COVID-19 Diagnostic Testing Introduction

11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.1.5 Cellex Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott COVID-19 Diagnostic Testing Introduction

11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche COVID-19 Diagnostic Testing Introduction

11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.3.5 Roche Recent Development

11.4 BioMedomics

11.4.1 BioMedomics Company Detail

11.4.2 BioMedomics Business Overview

11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction

11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.4.5 BioMedomics Recent Development

11.5 BD

11.5.1 BD Company Detail

11.5.2 BD Business Overview

11.5.3 BD COVID-19 Diagnostic Testing Introduction

11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.5.5 BD Recent Development

11.6 Henry Schein

11.6.1 Henry Schein Company Detail

11.6.2 Henry Schein Business Overview

11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction

11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.6.5 Henry Schein Recent Development

11.7 Safecare Bio-Tech

11.7.1 Safecare Bio-Tech Company Detail

11.7.2 Safecare Bio-Tech Business Overview

11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction

11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.7.5 Safecare Bio-Tech Recent Development

11.8 Mayo Clinic Laboratories

11.8.1 Mayo Clinic Laboratories Company Detail

11.8.2 Mayo Clinic Laboratories Business Overview

11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction

11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.8.5 Mayo Clinic Laboratories Recent Development

11.9 Chembio Diagnostics

11.9.1 Chembio Diagnostics Company Detail

11.9.2 Chembio Diagnostics Business Overview

11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction

11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.9.5 Chembio Diagnostics Recent Development

11.10 Mount Sinai Laboratory

11.10.1 Mount Sinai Laboratory Company Detail

11.10.2 Mount Sinai Laboratory Business Overview

11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction

11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.10.5 Mount Sinai Laboratory Recent Development

11.11 Ortho Clinical Diagnostics

11.11.1 Ortho Clinical Diagnostics Company Detail

11.11.2 Ortho Clinical Diagnostics Business Overview

11.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction

11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.11.5 Ortho Clinical Diagnostics Recent Development

11.12 Zhejiang Orient Gene Biotech

11.12.1 Zhejiang Orient Gene Biotech Company Detail

11.12.2 Zhejiang Orient Gene Biotech Business Overview

11.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction

11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.12.5 Zhejiang Orient Gene Biotech Recent Development

11.13 Innovita Biological Technology

11.13.1 Innovita Biological Technology Company Detail

11.13.2 Innovita Biological Technology Business Overview

11.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction

11.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.13.5 Innovita Biological Technology Recent Development

11.14 Guangzhou Wondfo Biotech

11.14.1 Guangzhou Wondfo Biotech Company Detail

11.14.2 Guangzhou Wondfo Biotech Business Overview

11.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction

11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.14.5 Guangzhou Wondfo Biotech Recent Development

11.15 Guangdong Hecin-Scientific

11.15.1 Guangdong Hecin-Scientific Company Detail

11.15.2 Guangdong Hecin-Scientific Business Overview

11.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction

11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.15.5 Guangdong Hecin-Scientific Recent Development

11.16 Dynamiker Biotechnology (Tianjin)

11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail

11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview

11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction

11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development

11.17 ADVAITE

11.17.1 ADVAITE Company Detail

11.17.2 ADVAITE Business Overview

11.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction

11.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2019-2024)

11.17.5 ADVAITE Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

ADVAITE

List of Tables

Table 1. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Nucleic Acid Testing

Table 3. Key Players of Antibody Testing

Table 4. Global COVID-19 Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global COVID-19 Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global COVID-19 Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global COVID-19 Diagnostic Testing Market Share by Region (2019-2024)

Table 8. Global COVID-19 Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global COVID-19 Diagnostic Testing Market Share by Region (2025-2030)

Table 10. COVID-19 Diagnostic Testing Market Trends

Table 11. COVID-19 Diagnostic Testing Market Drivers

Table 12. COVID-19 Diagnostic Testing Market Challenges

Table 13. COVID-19 Diagnostic Testing Market Restraints

Table 14. Global COVID-19 Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global COVID-19 Diagnostic Testing Market Share by Players (2019-2024)

Table 16. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Testing as of 2023)

Table 17. Ranking of Global Top COVID-19 Diagnostic Testing Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by COVID-19 Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players COVID-19 Diagnostic Testing Product Solution and Service

Table 21. Date of Enter into COVID-19 Diagnostic Testing Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2019-2024)

Table 25. Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2025-2030)

Table 27. Global COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global COVID-19 Diagnostic Testing Revenue Market Share by Application (2019-2024)

Table 29. Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global COVID-19 Diagnostic Testing Revenue Market Share by Application (2025-2030)

Table 31. North America COVID-19 Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe COVID-19 Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific COVID-19 Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America COVID-19 Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa COVID-19 Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Cellex Company Detail

Table 47. Cellex Business Overview

Table 48. Cellex COVID-19 Diagnostic Testing Product

Table 49. Cellex Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 50. Cellex Recent Development

Table 51. Abbott Company Detail

Table 52. Abbott Business Overview

Table 53. Abbott COVID-19 Diagnostic Testing Product

Table 54. Abbott Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 55. Abbott Recent Development

Table 56. Roche Company Detail

Table 57. Roche Business Overview

Table 58. Roche COVID-19 Diagnostic Testing Product

Table 59. Roche Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 60. Roche Recent Development

Table 61. BioMedomics Company Detail

Table 62. BioMedomics Business Overview

Table 63. BioMedomics COVID-19 Diagnostic Testing Product

Table 64. BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 65. BioMedomics Recent Development

Table 66. BD Company Detail

Table 67. BD Business Overview

Table 68. BD COVID-19 Diagnostic Testing Product

Table 69. BD Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 70. BD Recent Development

Table 71. Henry Schein Company Detail

Table 72. Henry Schein Business Overview

Table 73. Henry Schein COVID-19 Diagnostic Testing Product

Table 74. Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 75. Henry Schein Recent Development

Table 76. Safecare Bio-Tech Company Detail

Table 77. Safecare Bio-Tech Business Overview

Table 78. Safecare Bio-Tech COVID-19 Diagnostic Testing Product

Table 79. Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 80. Safecare Bio-Tech Recent Development

Table 81. Mayo Clinic Laboratories Company Detail

Table 82. Mayo Clinic Laboratories Business Overview

Table 83. Mayo Clinic Laboratories COVID-19 Diagnostic Testing Product

Table 84. Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 85. Mayo Clinic Laboratories Recent Development

Table 86. Chembio Diagnostics Company Detail

Table 87. Chembio Diagnostics Business Overview

Table 88. Chembio Diagnostics COVID-19 Diagnostic Testing Product

Table 89. Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 90. Chembio Diagnostics Recent Development

Table 91. Mount Sinai Laboratory Company Detail

Table 92. Mount Sinai Laboratory Business Overview

Table 93. Mount Sinai Laboratory COVID-19 Diagnostic Testing Product

Table 94. Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 95. Mount Sinai Laboratory Recent Development

Table 96. Ortho Clinical Diagnostics Company Detail

Table 97. Ortho Clinical Diagnostics Business Overview

Table 98. Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Product

Table 99. Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 100. Ortho Clinical Diagnostics Recent Development

Table 101. Zhejiang Orient Gene Biotech Company Detail

Table 102. Zhejiang Orient Gene Biotech Business Overview

Table 103. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Product

Table 104. Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 105. Zhejiang Orient Gene Biotech Recent Development

Table 106. Innovita Biological Technology Company Detail

Table 107. Innovita Biological Technology Business Overview

Table 108. Innovita Biological Technology COVID-19 Diagnostic Testing Product

Table 109. Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 110. Innovita Biological Technology Recent Development

Table 111. Guangzhou Wondfo Biotech Company Detail

Table 112. Guangzhou Wondfo Biotech Business Overview

Table 113. Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Product

Table 114. Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 115. Guangzhou Wondfo Biotech Recent Development

Table 116. Guangdong Hecin-Scientific Company Detail

Table 117. Guangdong Hecin-Scientific Business Overview

Table 118. Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Product

Table 119. Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 120. Guangdong Hecin-Scientific Recent Development

Table 121. Dynamiker Biotechnology (Tianjin) Company Detail

Table 122. Dynamiker Biotechnology (Tianjin) Business Overview

Table 123. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Product

Table 124. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 125. Dynamiker Biotechnology (Tianjin) Recent Development

Table 126. ADVAITE Company Detail

Table 127. ADVAITE Business Overview

Table 128. ADVAITE COVID-19 Diagnostic Testing Product

Table 129. ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)

Table 130. ADVAITE Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global COVID-19 Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global COVID-19 Diagnostic Testing Market Share by Type: 2023 VS 2030

Figure 3. Nucleic Acid Testing Features

Figure 4. Antibody Testing Features

Figure 5. Global COVID-19 Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global COVID-19 Diagnostic Testing Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Scientific Research Case Studies

Figure 9. COVID-19 Diagnostic Testing Report Years Considered

Figure 10. Global COVID-19 Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global COVID-19 Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global COVID-19 Diagnostic Testing Market Share by Region: 2023 VS 2030

Figure 13. Global COVID-19 Diagnostic Testing Market Share by Players in 2023

Figure 14. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Testing as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Diagnostic Testing Revenue in 2023

Figure 16. North America COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America COVID-19 Diagnostic Testing Market Share by Country (2019-2030)

Figure 18. United States COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe COVID-19 Diagnostic Testing Market Share by Country (2019-2030)

Figure 22. Germany COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific COVID-19 Diagnostic Testing Market Share by Region (2019-2030)

Figure 30. China COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America COVID-19 Diagnostic Testing Market Share by Country (2019-2030)

Figure 38. Mexico COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa COVID-19 Diagnostic Testing Market Share by Country (2019-2030)

Figure 42. Turkey COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Cellex Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 45. Abbott Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 46. Roche Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 47. BioMedomics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 48. BD Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 49. Henry Schein Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 50. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 51. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 52. Chembio Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 53. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 54. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 55. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 56. Innovita Biological Technology Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 57. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 58. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 59. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 60. ADVAITE Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-30I2390

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Healthcare Inventory Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6L2758

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

Blood Tubing Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-32Y957

Tue Oct 15 00:00:00 UTC 2024

Add to Cart

ePharmacy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-4C2008

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global COVID-19 Diagnostic Testing Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-32B5773

Global COVID-19 Diagnostic Testing Market Research Report 2024

FEATURED COMPANIES

COVID-19 Diagnostic Testing Market Size

COVID-19 Diagnostic Testing Market

Report Scope

Scope of COVID-19 Diagnostic Testing Market Report

Chapter Outline

FAQ for this report

Who are the main players in the COVID-19 Diagnostic Testing Market report?

What are the Application segmentation covered in the COVID-19 Diagnostic Testing Market report?

What are the Type segmentation covered in the COVID-19 Diagnostic Testing Market report?

FEATURED COMPANIES

RELATED REPORTS